CM-101 in NASH Patients - The SPLASH Study
NCT05824156
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class
Conditions
Nonalcoholic Steatohepatitis
Interventions
BIOLOGICAL:
5 mg/kg CM-101
OTHER:
Placebo
Sponsor
ChemomAb Ltd.